Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Study ID
- NCT07578675
- Status
- Recruiting
Conditions
- Aplastic Anemia
- Autoimmune Hemolytic Anemia
- Functional Near-Infrared Spectroscopy
- Myelodysplastic Syndromes
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Study Details
Anemia is a global public health concern and is closely linked to dysfunction of brain cognitive neural networks, a key mechanism underlying cognitive impairment. Such deficits-including declines in memory, learning, processing speed, and executive function-reduce daily living abilities and increase risks of falls and depression. Functional near-infrared spectroscopy (fNIRS) enables real-time monitoring of oxygenated and deoxygenated hemoglobin fluctuations, reflecting brain network function. This study aims to identify affected neural network regions in anemic patients and visualize connectivity changes using heatmaps and arc-based mapping. The findings will support early detection of cognitive impairment and guide precise clinical interventions, ultimately informing individualized treatment strategies to enhance therapeutic outcomes and quality of life.
Key Dates
- First listed
- May 11, 2026
- Start date
- Oct 11, 2025
- Status verified
- May 2026
- Primary completion
- Mar 31, 2028
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 323 participants (estimated)
Primary Outcome Measure
Concentration changes in oxygenated hemoglobin (HbO) and de-oxygenated hemoglobin (HbR) [ Time Frame: Patients will be assessed within 48 hours of admission. ]
Central Contacts
- ZheXiang Kuang, MSN13920361752
- Xiao Yu, Undergraduate18722218448
Related Studies
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerRecruiting · Barbara Ann Karmanos Cancer Institute · Detroit, Michigan
- Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina
- Registry of Older Patients With CancerRecruiting · UNC Lineberger Comprehensive Cancer Center · Boone, North Carolina
- Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic SyndromePHASE2 · Recruiting · M.D. Anderson Cancer Center · Houston, Texas